Trials / Not Yet Recruiting
Not Yet RecruitingNCT07198347
Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
A Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 3, randomized, double-blind, active-controlled clinical trial designed to evaluate the efficacy and safety of AG2001 in patients with acute bronchitis. The primary objective is to demonstrate the superiority of AG2001 over two active comparators based on the change in Bronchitis Severity Score (BSS) at Day 4.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG2001 | Oral administration, three times daily for 7 days. |
| DRUG | AG20011 | Oral administration, three times daily for 7 days. |
| DRUG | AG20012 | Oral administration, three times daily for 7 days. |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2026-03-31
- Completion
- 2026-10-31
- First posted
- 2025-09-30
- Last updated
- 2025-09-30
Source: ClinicalTrials.gov record NCT07198347. Inclusion in this directory is not an endorsement.